These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23054719)

  • 21. Augmented humoral and cellular immune response of hepatitis B virus DNA vaccine by micro-needle vaccination using Flt3L as an adjuvant.
    Zhou Q; Wang F; Yang F; Wang Y; Zhang X; Sun S
    Vaccine; 2010 Feb; 28(5):1357-62. PubMed ID: 19932674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanogram doses of alum-adjuvanted HBs antigen induce humoral immune response in mice when orally administered.
    Kapusta J; Pniewski T; Wojciechowicz J; Bociag P; Płucienniczak A
    Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):143-51. PubMed ID: 20165988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New hepatitis B vaccine formulated with an improved adjuvant system.
    Kundi M
    Expert Rev Vaccines; 2007 Apr; 6(2):133-40. PubMed ID: 17408363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin immunization with third-generation hepatitis B surface antigen using microneedles.
    Nguyen TT; Choi JA; Kim JS; Park H; Yang E; Lee WJ; Baek SK; Song M; Park JH
    Vaccine; 2019 Sep; 37(40):5954-5961. PubMed ID: 31466705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of humoral and cellular responses to HBsAg DNA vaccination by immunization with praziquantel through inhibition TGF-beta/Smad2,3 signaling.
    Zou Q; Zhong Y; Su H; Kang Y; Jin J; Liu Q; Geng S; Zhao G; Wang B
    Vaccine; 2010 Feb; 28(8):2032-8. PubMed ID: 20188260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
    Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantation.
    Scheiblhofer S; Strobl A; Hoepflinger V; Thalhamer T; Steiner M; Thalhamer J; Weiss R
    Vaccine; 2017 Mar; 35(14):1802-1809. PubMed ID: 28117172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Suppression of the antigen-specific T cell immune response by co-immunization with the HBV DNA vaccine and recombinant HBsAg].
    Du X; Wang J; Kang Y; Xiao W; Zhao G; Wang B
    Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):938-42. PubMed ID: 19873759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.
    Borges O; Cordeiro-da-Silva A; Tavares J; Santarém N; de Sousa A; Borchard G; Junginger HE
    Eur J Pharm Biopharm; 2008 Jun; 69(2):405-16. PubMed ID: 18364251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.
    Feng L; Qi XR; Zhou XJ; Maitani Y; Wang SC; Jiang Y; Nagai T
    J Control Release; 2006 May; 112(1):35-42. PubMed ID: 16516999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg.
    Milich DR; Chisari FV
    J Immunol; 1982 Jul; 129(1):320-5. PubMed ID: 6177755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen.
    Rahman F; Dahmen A; Herzog-Hauff S; Böcher WO; Galle PR; Löhr HF
    Hepatology; 2000 Feb; 31(2):521-7. PubMed ID: 10655280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humoral and cell-mediated immune-responses after administration of a single-shot recombinant hepatitis B surface antigen vaccine formulated with cationic poly(l-lactide) microspheres.
    Saini V; Jain V; Sudheesh MS; Dixit S; Gaur RL; Sahoo MK; Joseph SK; Verma SK; Jaganathan KS; Murthy PK; Kohli D
    J Drug Target; 2010 Apr; 18(3):212-22. PubMed ID: 19883203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development characterizations and evaluation of Poly(-ε-caprolactone)-based microspheres for hepatitis B surface antigen delivery.
    Tomar P; Karwasara VS; Dixit VK
    Pharm Dev Technol; 2011 Oct; 16(5):489-96. PubMed ID: 20550463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.
    Desombere I; Willems A; Gijbels Y; Leroux-Roels G
    J Virol; 2006 Apr; 80(7):3506-14. PubMed ID: 16537618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Specific cellular and humoral immune responses induced by intramuscular injection of DNA vaccine containing HBV HBsAg gene in mice].
    Liu S; Tan D; Li C
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):313-5. PubMed ID: 12080633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
    Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
    Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
    Li X; Yang X; Li L; Liu H; Liu J
    Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D visualisation of hepatitis B vaccine in the oral delivery vehicle SBA-15.
    Rasmussen MK; Kardjilov N; Oliveira CLP; Watts B; Villanova J; Botosso VF; Sant'Anna OA; Fantini MCA; Bordallo HN
    Sci Rep; 2019 Apr; 9(1):6106. PubMed ID: 30988384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant.
    Waters JA; Kennedy M; Voet P; Hauser P; Petre J; Carman W; Thomas HC
    J Clin Invest; 1992 Dec; 90(6):2543-7. PubMed ID: 1281839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.